Novogen Limited, Annual General Meeting, Oct 30, 2009, at 14:30 EAST-East Australian Standard GST. Location: Museum of Sydney, AGL Theatre, Level 2, corner of Phillip and Bridge Streets, Sydney, Australia. Agenda: To consider the financial reports of the company as at 30 June, 2009 and the reports of the directors and auditor thereon, in accordance with the corporations Act 2001; to approve the remuneration report; to approve the re-election of directors; to approve the issue of employee options to professor Alan Husband; to consider any other business as may be brought forward in accordance with the constitution of the company or the law and of which the requisite written notice has been given.

Novogen Limited reported earnings results for the year ended June 30, 2009. For the period, the company reported LBIT of AUD 23.8 million or AUD 0.2 per share, compared to AUD 24.7 million or AUD 0.2 per share, a year ago. Return on equity was negative at 82.7% compared to 69.5% a year ago. Return on assets was negative at 62.9% compared to 57.1% a year ago.

Novogen Limited reported audited consolidated and non-consolidated earnings results for the year ended June 30, 2009. For the period, the group earned gross revenues of $11.1 million versus $13.3 million in the previous corresponding period, a reduction of $2.2 million. The reduction in revenue was due to decreased sales of the Group's consumer health care products of $1.1 million or 11%. Other revenue also reduced by $1.1 million to $2.8 million verses $3.9 million for the previous corresponding period. The decrease in other revenue was mainly due to the reduced interest received on cash balances reflecting lower global interest rates. The operating loss attributable to Novogen shareholders for the financial year, after allowing for losses attributable to minority interests of $4.9 million, reduced by $1.4 million to $18.9 million from a loss of $20.3 million for the previous year. The net loss from ordinary activities after income tax for the consolidated group reduced by $1.0 million to $23.8 million from $24.8 million for the previous year. The reduction in the Group's net loss was due to reduced revenues and other incomes being offset by reduced expenditures. For the quarter, the group reported a loss before income tax of $23.8 million, loss for the period of $23.78 million and loss attributable to members of the company was $18.9 million or 18.6 cents per share against loss before income tax of $24.8 million, loss for the period of $24.7 million and loss attributable to members of the company was $20.3 million or 20.8 cents per share for the same period a year ago. Net cash flows used in operating activities was $20.6 million against $20.1 million for the same period a year ago. The company spent $94,000 on acquisition of property, plant and equipment against $95,000 for the same period a year ago. For the quarter, the company reported a loss before income tax and loss for the period of $7.2 million on the revenue of $2.1 million against loss before income tax, loss for the period and loss attributable to members of the company was $3.6 million on the revenue of $1.3 million for the same period a year ago. Net cash flows used in operating activities was $1.1 million against $1.5 million for the same period a year ago. The company spent $6.7 million on investment in subsidiary against $0.8 million for the same period a year ago.